Skip to content

Intimacy of Women With Cystic Fibrosis

Intimacy of Women With Cystic Fibrosis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04225962
Acronym
IFAM
Enrollment
211
Registered
2020-01-13
Start date
2019-11-19
Completion date
2021-05-18
Last updated
2022-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mucoviscidosis

Keywords

Cystic fibrosis, Women, Private life, Sexual disorders, Quality of sex life

Brief summary

The intimate life of patients with cystic fibrosis has not been the subject of specific research, it is even left behind in favor of respiratory, digestive or endocrinological dysfunctions endangering these patients. After 16 years of practice, it is significant that this subject is problematic, painful but difficult to tackle; No doubt just as much on the side of caregivers: this question has never found its way into team exchanges, it seems to be evaded doubtless difficult or too intimate to welcome. These disorders arise from the effects of the disease on the health of the mucous epithelial tissues also located in the genital area. These difficulties are more closely approached by the difficulties of procreation; PMA allows them to get around them, nevertheless making it possible to be a parent, with the residual frustration of a satisfactory sex life: a deaf addition, adding to many care constraints. It is therefore in terms of sexual health and quality of sexual life that it is desirable to shed light on this aspect of cystic fibrosis in women. Bibliographic research confirms this approach: this subject is not explored, the rare publications concern the vulnerability of the cervix or the difficulty on both sides of tackling this subject.

Interventions

OTHERIntimate quality of life questionnaire

Preparation of an intimate quality of life questionnaire

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Major women with cystic fibrosis * Tracked in the various CRCMs in France, * Having or having had sexual intercourse, * Having previously been informed of the aims and confidentiality of this research and not having opposed their participation.

Exclusion criteria

* Major women with cystic fibrosis whose state of health (acute episode of their disease or worsening phase) does not lend itself to such a collection * Adult women with cystic fibrosis who are unable to receive the information and make a non-objection

Design outcomes

Primary

MeasureTime frameDescription
Assessment of specific intimate disorders of patients with cystic fibrosis12 monthsPassing a questionnaire to assess patients' intimate quality of life. The responses to binary qualitative variables will be described by proportions. The responses to the 5-modality ordinal qualitative variables will be described by the median and the range (minimum and maximum). Continuous quantitative variables will be described by the mean and its standard deviation.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026